SCHEMBL11058449

SCHEMBL11058449

CC(F)(CO)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 2/20 0.43
HIF1A Q16665 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43
ALOX15 P16050 1/20 0.43
ESR1 P03372 2/20 0.41
ESR2 Q92731 2/20 0.41
PTPN1 P18031 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPK1 P28482 1/20 0.41
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10494089 0.82 ALDH1A1 (0.42) ALDH1A1TSHRCYP2C19HIF1ATAAR1
SCHEMBL25451215 0.79 ACHE (0.49) ALDH1A1ALOX15ESR1ESR2MAPT
SCHEMBL3627861 0.78 ALDH1A1 (0.48) ALDH1A1TSHRCYP2C19HIF1ATAAR1
SCHEMBL17885859 0.78 ALDH1A1 (0.48) ALDH1A1TSHRCYP2C19HIF1ATAAR1
SCHEMBL28318280 0.77 MEN1 (0.52) TSHRCYP2C19HIF1AMAPK1KMT2A
SCHEMBL5012067 0.77 TSHR (0.52) ALDH1A1TSHRCYP2C19HIF1ATAAR1
SCHEMBL17885867 0.76 ALDH1A1 (0.46) ALDH1A1TSHRCYP2C19HIF1ATAAR1
SCHEMBL8528106 0.76 ALDH1A1 (0.46) ALDH1A1TSHRCYP2C19HIF1ATAAR1
SCHEMBL23555497 0.76 LPL (0.39) ALDH1A1CYP2C19TAAR1ESR1ESR2
SCHEMBL20327636 0.76 CA1 (0.46) ALDH1A1TAAR1MAPK1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101180263-B Process for preparing substituted tetrafluorobenzylaniline compounds and pharmaceutically acceptable salts thereof CHOONGWAE PHARMA CORP 2011-11-02 CN disclosed
CN-101180263-A Process for preparing substituted tetrafluorobenzylaniline compounds and pharmaceutically acceptable salts thereof CHOONGWAE PHARMA CORP (KR) 2008-05-14 CN disclosed
EP-0122452-A1 Triazolyl- and imidazolyl-substituted fluoroalkane derivatives, process for their preparation and pharmaceutical compositions containing them SCHERING CORPORATION (US) 1984-10-24 EP disclosed